Skip to main content

Reviva Pharmaceuticals Holdings, Inc 10-Q for FY2026 Q3

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

10-Q 2026-11-13 For: 2026-09-30
View Original
Added on November 13, 2026

About this 10-Q

Reviva Pharmaceuticals Holdings, Inc filed this 10-Q on November 13, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Reviva Pharmaceuticals Holdings, Inc. said cash and cash equivalents were approximately $17.5 million as of September 30, 2026, but current cash would not satisfy operating needs for 12 months, raising substantial doubt about its ability to continue as a going concern. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$2.3M
compared with a net loss of $4.01M a year earlier